» Articles » PMID: 27399992

Fertility Treatments in the United States: Improving Access and Outcomes

Overview
Journal Obstet Gynecol
Date 2016 Jul 12
PMID 27399992
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The recently released National Public Health Action Plan for the Detection, Prevention, and Management of Infertility calls for better access to high-quality infertility services and improved safety of fertility treatments. Both assisted reproductive technology (ART) and non-ART fertility treatments have allowed millions of patients worldwide to overcome infertility-a disease of the reproductive system and important public health issue. However, there are substantial disparities in access to effective treatments in the United States, largely attributable to high out-of-pocket costs, especially for ART. Moreover, the outcomes of fertility treatments are often complicated by the large proportion of multiple births with substantial health risks for both neonates and mothers. Prevention of multiple births is difficult during non-ART fertility treatments but can be effective with single-embryo transfer during ART. Several U.S. states have enacted legislative mandates that require private insurers to cover some portion of the costs associated with fertility treatments and thus reduce the financial pressure to transfer multiple embryos during ART. Although studies have shown that insurance coverage reduces per-cycle multiple births to a certain degree, states with insurance mandates have more ART-related multiple births attributable to substantially larger number of ART-conceived neonates. Experience from other countries shows that access to ART can be improved without concomitant increases in multiple births by providing reimbursement for ART in combination with restrictions on the number of embryos transferred per cycle. Such approaches may or may not be successful in the United States with its unique and complex health care system.

Citing Articles

Epidemiological characteristics of infertility, 1990-2021, and 15-year forecasts: an analysis based on the global burden of disease study 2021.

Feng J, Wu Q, Liang Y, Liang Y, Bin Q Reprod Health. 2025; 22(1):26.

PMID: 39972325 PMC: 11841318. DOI: 10.1186/s12978-025-01966-7.


Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis.

Khair A, Brown T, Markert M, Barsoe C, Daftary G, Heiser P Pharmacoecon Open. 2023; 7(5):851-860.

PMID: 37480456 PMC: 10471533. DOI: 10.1007/s41669-023-00429-8.


The Future of Assisted Reproductive Technology Live Births in the United States.

Tierney K Popul Res Policy Rev. 2022; 41(5):2289-2309.

PMID: 35874801 PMC: 9289087. DOI: 10.1007/s11113-022-09731-5.


Access to Fertility Care in Geographically Underserved Populations, a Second Look.

Brodeur T, Grow D, Esfandiari N Reprod Sci. 2022; 29(7):1983-1987.

PMID: 35680726 PMC: 9181892. DOI: 10.1007/s43032-022-00991-2.


Worldwide trend analysis of primary and secondary infertility rates over past decades: A cross-sectional study.

Borumandnia N, Alavi Majd H, Khadembashi N, Alaii H Int J Reprod Biomed. 2022; 20(1):37-46.

PMID: 35308328 PMC: 8902794. DOI: 10.18502/ijrm.v20i1.10407.


References
1.
Kissin D, Kulkarni A, Mneimneh A, Warner L, Boulet S, Crawford S . Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril. 2015; 103(4):954-61. PMC: 4607049. DOI: 10.1016/j.fertnstert.2014.12.127. View

2.
van Loendersloot L, Repping S, Bossuyt P, van der Veen F, van Wely M . Prediction models in in vitro fertilization; where are we? A mini review. J Adv Res. 2015; 5(3):295-301. PMC: 4294714. DOI: 10.1016/j.jare.2013.05.002. View

3.
Martin J, Bromer J, Sakkas D, Patrizio P . Insurance coverage and in vitro fertilization outcomes: a U.S. perspective. Fertil Steril. 2010; 95(3):964-9. DOI: 10.1016/j.fertnstert.2010.06.030. View

4.
Chambers G, Illingworth P, Sullivan E . Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia. Med J Aust. 2011; 195(10):594-8. DOI: 10.5694/mja10.11448. View

5.
Kanter J, Boulet S, Kawwass J, Jamieson D, Kissin D . Trends and correlates of monozygotic twinning after single embryo transfer. Obstet Gynecol. 2015; 125(1):111-117. PMC: 4515956. DOI: 10.1097/AOG.0000000000000579. View